BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 16198277)

  • 1. Hypertension in children with chronic kidney disease.
    Shatat IF; Flynn JT
    Adv Chronic Kidney Dis; 2005 Oct; 12(4):378-84. PubMed ID: 16198277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [New aspects of hypertension management in patients with chronic kidney disease].
    Vakilzadeh N; Phan O; Forni Ogna V; Burnier M; Wuerzner G
    Rev Med Suisse; 2014 Sep; 10(441):1668-72. PubMed ID: 25322626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypertension and chronic kidney disease.
    Jose VJ
    Indian Heart J; 2010; 62(5):410-5. PubMed ID: 23189882
    [No Abstract]   [Full Text] [Related]  

  • 4. Renin-angiotensin-aldosterone system intervention in the cardiometabolic syndrome and cardio-renal protection.
    Whaley-Connell A; Pavey BS; Chaudhary K; Saab G; Sowers JR
    Ther Adv Cardiovasc Dis; 2007 Oct; 1(1):27-35. PubMed ID: 19124393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of the renin-angiotensin system in the pathophysiology, prevention, and treatment of renal impairment in patients with the cardiometabolic syndrome or its components.
    Alpert MA; Govindarajan G; Del Rosario ML; Reisin E
    J Cardiometab Syndr; 2009; 4(1):57-62. PubMed ID: 19245518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hypertension and renal disease].
    Kamper AL; Pedersen EB; Strandgaard S
    Ugeskr Laeger; 2009 Jun; 171(25):2109-13. PubMed ID: 19671393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of obesity and its bioclinical correlates in the progression of chronic kidney disease.
    Chalmers L; Kaskel FJ; Bamgbola O
    Adv Chronic Kidney Dis; 2006 Oct; 13(4):352-64. PubMed ID: 17045221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood-pressure control and delay in progression of kidney disease in children.
    Ingelfinger JR
    N Engl J Med; 2009 Oct; 361(17):1701-3. PubMed ID: 19846857
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hypertension and kidney].
    Abe T
    Nihon Jinzo Gakkai Shi; 2013; 55(1):28-34. PubMed ID: 23461207
    [No Abstract]   [Full Text] [Related]  

  • 10. Prerenal success in chronic kidney disease.
    Hirsch S
    Am J Med; 2007 Sep; 120(9):754-9. PubMed ID: 17765040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Importance of blood pressure control in chronic kidney disease.
    Ravera M; Re M; Deferrari L; Vettoretti S; Deferrari G
    J Am Soc Nephrol; 2006 Apr; 17(4 Suppl 2):S98-103. PubMed ID: 16565257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arterial hypertension and progression of chronic kidney disease in children during 10-year ambulatory observation.
    Ksiazek A; Klosowska J; Sygulla K; Adamczyk P; Ziora K; Szczepanska M
    Clin Exp Hypertens; 2013; 35(6):424-9. PubMed ID: 23199347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progression of chronic kidney disease: can it be prevented or arrested?
    Jaber BL; Madias NE
    Am J Med; 2005 Dec; 118(12):1323-30. PubMed ID: 16378772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The renoprotective effects of RAS inhibition: focus on prevention and treatment of chronic kidney disease.
    Weir MR
    Postgrad Med; 2009 Jan; 121(1):96-103. PubMed ID: 19179817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stepwise increase in the prevalence of isolated systolic hypertension with the stages of chronic kidney disease.
    Cheng LT; Gao YL; Gu Y; Zhang L; Bi SH; Tang W; Wang T
    Nephrol Dial Transplant; 2008 Dec; 23(12):3895-900. PubMed ID: 18632588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Salt-Induced Reno-Cerebral Reflex Activates Renin-Angiotensin Systems and Promotes CKD Progression.
    Cao W; Li A; Wang L; Zhou Z; Su Z; Bin W; Wilcox CS; Hou FF
    J Am Soc Nephrol; 2015 Jul; 26(7):1619-33. PubMed ID: 25635129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Common pathophysiological mechanisms of chronic kidney disease: therapeutic perspectives.
    López-Novoa JM; Martínez-Salgado C; Rodríguez-Peña AB; López-Hernández FJ
    Pharmacol Ther; 2010 Oct; 128(1):61-81. PubMed ID: 20600306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of mild hyperuricemia on urinary transforming growth factor beta and the progression of chronic kidney disease.
    Talaat KM; el-Sheikh AR
    Am J Nephrol; 2007; 27(5):435-40. PubMed ID: 17622758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The endothelin system and its antagonism in chronic kidney disease.
    Dhaun N; Goddard J; Webb DJ
    J Am Soc Nephrol; 2006 Apr; 17(4):943-55. PubMed ID: 16540557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obesity, cardiometabolic syndrome, and chronic kidney disease: the weight of the evidence.
    Lastra G; Manrique C; Sowers JR
    Adv Chronic Kidney Dis; 2006 Oct; 13(4):365-73. PubMed ID: 17045222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.